A trial looking at 177 Lutetium DOTATATE for neuroblastoma in children and young people (LuDO)

Overview

Cancer types:

Children's cancers, Neuroblastoma

Status:

Results

Phase:

Phase 2

Details

This trial looked at a drug called 177 Lutetium DOTATATE (LuDO) to improve treatment for children and young people with neuroblastoma. It was for people whose cancer had come back or treatment had stopped working.

This trial was for children and young people up to the age of 18. We use the term 'you' in this summary, but of course if you are a parent, we are referring to your child.

Cancer Research UK supported this trial.

This trial was open for people to join between 2013 and 2017, and the team published the results in 2020.

Recruitment start: 19 September 2013

Recruitment end: 23 July 2017